272 related articles for article (PubMed ID: 30904564)
1. Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders.
Pedrini M; Cao B; Nani JVS; Cerqueira RO; Mansur RB; Tasic L; Hayashi MAF; McIntyre RS; Brietzke E
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():182-188. PubMed ID: 30904564
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review.
MacDonald K; Krishnan A; Cervenka E; Hu G; Guadagno E; Trakadis Y
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):122-137. PubMed ID: 30411484
[TBL] [Abstract][Full Text] [Related]
3. Novel strategies for clinical investigation and biomarker discovery: a guide to applied metabolomics.
Carneiro G; Radcenco AL; Evaristo J; Monnerat G
Horm Mol Biol Clin Investig; 2019 Jan; 38(3):. PubMed ID: 30653466
[TBL] [Abstract][Full Text] [Related]
4. Advances in metabolite identification.
Wishart DS
Bioanalysis; 2011 Aug; 3(15):1769-82. PubMed ID: 21827274
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics toward personalized medicine.
Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
[TBL] [Abstract][Full Text] [Related]
6. Analytical pitfalls and challenges in clinical metabolomics.
Kohler I; Verhoeven A; Derks RJ; Giera M
Bioanalysis; 2016 Jul; 8(14):1509-32. PubMed ID: 27323646
[TBL] [Abstract][Full Text] [Related]
7. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
8. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
9. Innovation in metabolomics to improve personalized healthcare.
Cacciatore S; Loda M
Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
11. Method validation strategies involved in non-targeted metabolomics.
Naz S; Vallejo M; García A; Barbas C
J Chromatogr A; 2014 Aug; 1353():99-105. PubMed ID: 24811151
[TBL] [Abstract][Full Text] [Related]
12. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
Cui L; Lu H; Lee YH
Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics in multiple sclerosis.
Bhargava P; Calabresi PA
Mult Scler; 2016 Apr; 22(4):451-60. PubMed ID: 26754801
[TBL] [Abstract][Full Text] [Related]
14. Personalized Metabolic Profile by Synergic Use of NMR and HRMS.
Petrella G; Montesano C; Lentini S; Ciufolini G; Vanni D; Speziale R; Salonia A; Montorsi F; Summa V; Vago R; Orsatti L; Monteagudo E; Cicero DO
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299442
[TBL] [Abstract][Full Text] [Related]
15. Personalized Medicine and Mood Disorders.
Alhajji L; Nemeroff CB
Psychiatr Clin North Am; 2015 Sep; 38(3):395-403. PubMed ID: 26300030
[TBL] [Abstract][Full Text] [Related]
16. Personalized Metabolomics.
Marciano DP; Snyder MP
Methods Mol Biol; 2019; 1978():447-456. PubMed ID: 31119679
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics Biomarkers for Precision Psychiatry.
Shih PB
Adv Exp Med Biol; 2019; 1161():101-113. PubMed ID: 31562625
[TBL] [Abstract][Full Text] [Related]
18. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.
Marshall DD; Powers R
Prog Nucl Magn Reson Spectrosc; 2017 May; 100():1-16. PubMed ID: 28552170
[TBL] [Abstract][Full Text] [Related]
19. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
Dona AC; Coffey S; Figtree G
Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
